2 citations
,
February 2023 in “International journal of molecular sciences”
This study explored a multidimensional approach to examine bodyhairs' physico-chemical properties, potentially supporting their use over scalp hairs in forensic and intoxication studies.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
This study suggests that 3D bioprinting may become a practical solution for tissue regeneration and complex wound care, demonstrating improved outcomes over traditional methods in various applications.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)”
This study demonstrates that 3D bioprinting is advancing toward practical use in reconstructive medicine, with promising results in personalized skin grafts, hair regeneration, and burn care, despite existing technical and ethical challenges.
This study found that keratin phenotypes were consistent across different types of hair from the same individual, allowing for successful keratin typing following ABH blood group determination.
Transplanting mice skin to humans is not feasible due to immune rejection, but some suggest genetic modification or immune suppression could make it possible. Xenograft hair transplants are discouraged.
Bodyhair is more resilient than scalp hair due to different gene expressions and DHT sensitivity. Treatments like minoxidil and finasteride are used for hair loss, but they have varying effects on body and scalp hair.
There have been no new effective hair loss treatments since finasteride, despite technological advancements. Current treatments include finasteride, minoxidil, and RU58841, with ongoing challenges and potential future solutions in research.
Vitamin D may counteract DHT and help with hair growth, as seen in mice and humanhair cultures. Some users discuss using Vitamin D, magnesium, and other supplements for hair health, while others humorously note the success in mice.
Rubedo Life Sciences is developing a GPX4 modulator, RLS-1496, for hair loss treatment, showing promising hair follicle growth in early tests. Concerns include potential side effects like organ damage, with a realistic market release several years away.
Is topical Vitamin C effective for scalp and hair growth?No human trial has shown that topical vitamin C improves hair growth or scalp health. Its skin trials were on other body sites, and the hair data come from laboratory studies.
How does tofacitinib differ when used orally versus topically in hair loss treatment research?Oral tofacitinib acts on immune signalling throughout the body and has more published regrowth data in alopecia areata (from small studies without placebo groups), alongside an FDA boxed warning; topical tofacitinib aims to act only on the scalp, but the human evidence is a handful of small compounded-formulation studies with no large randomized trial. Neither route is approved for hair loss, and regrowth generally reverses after treatment stops.